Clinical Trial Update: Preference on the Feedback Mechanisms of Dose Delivery Confirmation With the Breezhaler® Device Compared to the Ellipta® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD) [NA]

View source ↗

Summary

Clinical trial comparing feedback mechanisms for dose delivery between Breezhaler and Ellipta devices in COPD patients; study completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Breezhaler
• ELLIPTA

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Pulmonary Disease, Chronic Obstructive (COPD) | NA | Status: COMPLETED | Results posted: 2017-10-09